malondialdehyde has been researched along with piroxicam in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dowling, EJ; Parke, DV; Symons, AM | 1 |
| Facoory, B; Faed, JM; McQueen, EG | 1 |
| Cabrera, G; Corona, S; Piña, E; Rocha-Hernández, AE; Saldaña Balmori, Y; Zentella de Piña, M | 1 |
| Bartosiewicz, G; Mézes, M; Német, J | 1 |
| Ahouandjivo, R; Baudrimont, I; Creppy, EE | 1 |
| Abramo, A; Antonioli, L; Baldi, S; Blandizzi, C; Carazzina, G; Colucci, R; Del Tacca, M; Fornai, M; Lubrano, V; Natale, G; Tuccori, M | 1 |
| Aydin, ON; Doger, FK; Dost, T; Karul, A; Sen, S | 1 |
| Ayan, E; Ayaz, L; Bayram Kaplan, M; Karabacak, T; Koksel, O; Ozdulger, A; Tamer, L | 1 |
| Bhattacharya, P; Pandey, AK; Patnaik, R; Paul, S; Yavagal, DR | 1 |
| Bayram, E; Cetin, I; Civi, M; Topcu, I; Var, A; Vatansever, S | 1 |
| Abdeen, A; Abdel-Daim, M; Abdel-Maksoud, HA; Abdelkader, A; Abdelnaby, A; Abo-Ahmed, AI; Abou-Zaid, OA; Aboubakr, M; Aleya, L; El-Mleeh, A; Mostafa, O | 1 |
| Abdeen, A; Abdel-Daim, M; Abdelkader, A; Abdulah, OA; Aboubakr, M; El-Mleeh, A; El-Serehy, HA; Elgazzar, D; Najda, A; Shoghy, K | 1 |
2 trial(s) available for malondialdehyde and piroxicam
| Article | Year |
|---|---|
Non-steroidal anti-inflammatory drugs and platelet function.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Diflunisal; Female; Humans; Male; Malondialdehyde; Middle Aged; Naproxen; Piroxicam; Sulindac; Time Factors | 1986 |
Changes in lipid, peroxide, and anti-oxidant blood levels during piroxicam (Hotemin) treatment.
Topics: Adult; Aged; Arthritis, Rheumatoid; Catalase; Female; Glutathione Peroxidase; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Osteoarthritis; Piroxicam; Vitamin E | 1993 |
10 other study(ies) available for malondialdehyde and piroxicam
| Article | Year |
|---|---|
Lipid peroxidation, free radicals and experimental inflammation.
Topics: Animals; Diclofenac; Disease Models, Animal; Edema; Free Radicals; Indomethacin; Inflammation; Lipid Peroxidation; Luminescent Measurements; Male; Malondialdehyde; Piroxicam; Prednisolone; Rats; Rats, Inbred Strains; Reference Values | 1988 |
Restoration by piroxicam of liver glutathione levels decreased by acute ethanol intoxication.
Topics: Alcoholic Intoxication; Animals; Ethanol; Glucose; Glutathione; Glutathione Disulfide; Liver; Male; Malondialdehyde; Piroxicam; Rats; Rats, Wistar; Reference Values; Triglycerides | 1994 |
Prevention of lipid peroxidation induced by ochratoxin A in Vero cells in culture by several agents.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspartame; Catalase; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Free Radical Scavengers; Lipid Peroxidation; Malondialdehyde; Molecular Structure; Mycotoxins; Ochratoxins; Piroxicam; Reactive Oxygen Species; Superoxide Dismutase; Thiobarbiturates; Vero Cells | 1997 |
Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Benzimidazoles; Diclofenac; Dose-Response Relationship, Drug; Gastric Acid; Gastric Mucosa; Glutathione; Indomethacin; Ligation; Lipoproteins, LDL; Male; Malondialdehyde; Omeprazole; Oxidation-Reduction; Pantoprazole; Peroxidase; Piroxicam; Proton Pump Inhibitors; Pylorus; Rats; Rats, Wistar; Sulfoxides | 2005 |
The protective effect of nitroglycerin on gastrointestinal and renal side effects of lornoxicam in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Catalase; Drug Therapy, Combination; Gastric Mucosa; Gastrointestinal Diseases; Glutathione; Interleukin-6; Kidney; Kidney Diseases; Male; Malondialdehyde; Nitroglycerin; Piroxicam; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Vasodilator Agents | 2006 |
Efficiency of lornoxicam in lung and trachea injury caused by peroxynitrite.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bronchoalveolar Lavage Fluid; Female; Lung; Male; Malondialdehyde; Peroxidase; Peroxynitrous Acid; Piroxicam; Rats; Respiratory Distress Syndrome; Trachea; Tracheal Diseases; Tyrosine | 2008 |
Aquaporin-4 inhibition mediates piroxicam-induced neuroprotection against focal cerebral ischemia/reperfusion injury in rodents.
Topics: Animals; Aquaporin 4; Brain; Brain Edema; Brain Infarction; Brain Ischemia; Calcium; Dose-Response Relationship, Drug; Male; Malondialdehyde; Neuroprotective Agents; Nitrites; Piroxicam; Rats; Reperfusion Injury; Rotarod Performance Test; Stroke | 2013 |
The effects of lornoxicam on neuroprotection following diffuse traumatic brain injury in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Brain Injuries; Caspases; Glutathione Peroxidase; Immunohistochemistry; In Situ Nick-End Labeling; Injections, Intraperitoneal; Male; Malondialdehyde; Neuroprotective Agents; Piroxicam; Rats; Rats, Wistar; Superoxide Dismutase | 2013 |
Cadmium overload modulates piroxicam-regulated oxidative damage and apoptotic pathways.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Cadmium; Creatinine; Kidney; Liver; Male; Malondialdehyde; Oxidative Stress; Piroxicam; Rats; Rats, Wistar | 2019 |
Coenzyme Q10 supplementation mitigates piroxicam-induced oxidative injury and apoptotic pathways in the stomach, liver, and kidney.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Caspase 3; COVID-19; Dietary Supplements; Free Radical Scavengers; Kidney; Liver; Male; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; Piroxicam; Rats; Rats, Wistar; Reactive Oxygen Species; Stomach; Stomach Ulcer; Ubiquinone | 2020 |